Drug Profile
Cholic acid - Laboratoires CTRS
Alternative Names: OrphacolLatest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator Laboratoires CTRS
- Developer Immedica; Laboratoires CTRS
- Class Choleretics; Cholic acids; Gallstone therapies; Small molecules
- Mechanism of Action Farnesoid X-activated receptor modulators; Sodium-bile acid cotransporter modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Inborn genetic disorders
Most Recent Events
- 28 Jan 2021 No recent reports of development identified for clinical-Phase-Unknown development in Inborn genetic disorders(In children) in Germany (PO, Tablet)
- 28 Jan 2021 No recent reports of development identified for clinical-Phase-Unknown development in Inborn genetic disorders(In children) in Italy (PO, Tablet)
- 28 Jan 2021 No recent reports of development identified for clinical-Phase-Unknown development in Inborn genetic disorders(In children) in Switzerland (PO, Tablet)